‘Humanized’ mouse may offer liver disease treatments
February 23rd, 2010 - 2:00 pm ICT by ANI ( Leave a comment )Washington, Feb 23 (ANI): Scientists have generated a mouse with an almost complete human liver.
The team, led by Salk Institute researchers, says this ‘humanized’ mouse is susceptible to human liver infections and responds to human drug treatments, providing a new way to test novel therapies for debilitating human liver diseases and other diseases with liver involvement such as malaria.
“We found that, not only can we infect our humanized mouse with Hepatitis B and Hepatitis C, but we can then successfully treat this infection using typical drugs,” said first author Karl-Dimiter Bissig, an internist and post-doctoral researcher in the Laboratory of Genetics.
“As a physician, I understand the importance of this type of bench-to-bedside research. This study shows a real application for our mouse model, making it relevant from both an academic and a clinical perspective,” Bissig added.
The findings will be published in the Feb. 22, 2010 online edition of the Journal of Clinical Investigation. (ANI)
- Shark liver compound could treat dengue, hepatitis - Sep 20, 2011
- Healing damaged liver tissues - Dec 05, 2011
- New class of compounds to combat malaria - Nov 20, 2011
- Dispersing fungal spores over water kills malaria mosquito larvae - Feb 21, 2011
- Fancy a tattoo? Beware of hepatitis virus (July 28 is World Hepatitis Day) - Jul 28, 2011
- Now, 'needle-free' natural vaccine against malaria - Aug 12, 2010
- New way found to kill malaria parasite - Mar 09, 2011
- Integrate Hepatitis C testing with HIV: NGOs - Oct 21, 2011
- New discovery opens up novel strategy for combating malaria - Mar 09, 2011
- Genetic variation linked to liver cirrhosis in alcoholic Caucasians identified - Dec 17, 2010
- Tuberculosis enzyme responsible for lung destruction identified - Apr 26, 2011
- Trials start on potent new hepatitis C drug - May 15, 2010
- Vaccine slashes malaria risk by half - Jan 14, 2011
- Liver, not brain, may be source of Alzheimer's plaques - Mar 04, 2011
- Mosquitoes themselves may one day become anti-malaria `syringes' - Aug 30, 2010
Tags: bench to bedside, clinical perspective, doctoral researcher, drugs, genetics, hepatitis, hepatitis b, hepatitis c, human liver, institute researchers, journal of clinical investigation, liver disease, liver diseases, liver involvement, malaria, mouse model, novel therapies, salk institute, scientists
